NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Results
Company to Host Conference Call and Webcast March 31, 2022, at 8:30am ET RADNOR, Pa., March 31, 2022 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”), a clinical-stage, biopharmaceutical company, today announced its financial results for the year ended…
Comments Off on NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Results